DCM
IART icon

Davis Capital Management’s Integra LifeSciences IART Stock Holding History

Davis Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72 Buy
+4
New +$56 ﹤0.01% 1142

Other funds holding IART

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Davis Capital Management's IART Position: Q2 2026 in Review

Davis Capital Management opened a new position in Integra LifeSciences (IART) in Q2 2026: 4 shares worth $72. The stake represents ﹤0.01% of the portfolio and ranks #1142 among its holdings.

33 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Davis Capital Management held 4 shares of Integra LifeSciences worth $72 as of Q2 2026.
  • Integra LifeSciences was a new Davis Capital Management position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1142 holding.
  • 33 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.